Current Trends and Emerging Challenges in Clinical Chemistry Analyzer Market

Posted August 23, 2018 by akshayjadhav

Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019

The global clinical chemistry analyzer market was valued at $8,965.00 million in 2014 and is poised to grow at a CAGR of 5.52% between 2014and 2019, to reach $11,728.01 million in 2019. Rapid growth in the diagnostics market, increase in the healthcare spending, and increasing incidence in lifestyle disease will drive the growth of the market. Furthermore, increasing awareness for preventative healthcare, increase in aging population, increase in reagent rental agreements and increasing demand for laboratory automation will aid the demand for clinical chemistry analyzer products.

This report segment the clinical chemistry analyzer market on the basis of products, test, end users and regions. The product segments included in this report are analyzers, reagents and other products. The clinical chemistry analyzer product segment is further divided on the basis of type into four segments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), Very large (2,000 Tests/H). The reagents product segment is further categorized into calibrators, controls, standards and other reagents. The tests segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. The end-user segments included in this report are academic research institutes, diagnostic laboratories, hospitals, and other end users.

The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW). The geographic analysis reveals that Americas accounted for the largest share in the global market in 2014. The BRIC regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for automation from this region.

Seak to Analyst:

The major players in the market include Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific(U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup(France), Mindray (China), Horiba (Japan).

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country United States
Categories Biotech , Health , Medical
Tags clinical chemistry analyzer market
Last Updated August 23, 2018